ATE231973T1 - Verfahren zur elimination der interferenz des rheumatoiden faktors in diagnostischen tests - Google Patents

Verfahren zur elimination der interferenz des rheumatoiden faktors in diagnostischen tests

Info

Publication number
ATE231973T1
ATE231973T1 AT96927361T AT96927361T ATE231973T1 AT E231973 T1 ATE231973 T1 AT E231973T1 AT 96927361 T AT96927361 T AT 96927361T AT 96927361 T AT96927361 T AT 96927361T AT E231973 T1 ATE231973 T1 AT E231973T1
Authority
AT
Austria
Prior art keywords
solid phase
phase material
rheumatoid factors
rheumatoid
igg antibodies
Prior art date
Application number
AT96927361T
Other languages
English (en)
Inventor
Jerzy A Macioszek
John M Robinson
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE231973T1 publication Critical patent/ATE231973T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/902—Streptomyces olivaceus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT96927361T 1995-08-18 1996-08-09 Verfahren zur elimination der interferenz des rheumatoiden faktors in diagnostischen tests ATE231973T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/516,719 US5698393A (en) 1995-08-18 1995-08-18 Method for elimination of rheumatoid factor interference in diagnostic assays
PCT/US1996/012955 WO1997007401A1 (en) 1995-08-18 1996-08-09 Method for elimination of rheumatoid factor interference in diagnostic assays

Publications (1)

Publication Number Publication Date
ATE231973T1 true ATE231973T1 (de) 2003-02-15

Family

ID=24056820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96927361T ATE231973T1 (de) 1995-08-18 1996-08-09 Verfahren zur elimination der interferenz des rheumatoiden faktors in diagnostischen tests

Country Status (8)

Country Link
US (1) US5698393A (de)
EP (1) EP0846268B1 (de)
JP (1) JP3675837B2 (de)
AT (1) ATE231973T1 (de)
CA (1) CA2230644A1 (de)
DE (1) DE69626027T2 (de)
ES (1) ES2192611T3 (de)
WO (1) WO1997007401A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6416952B1 (en) 1989-06-07 2002-07-09 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US6506558B1 (en) 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
DE69132843T2 (de) 1990-12-06 2002-09-12 Affymetrix Inc N D Ges D Staat Identifizierung von Nukleinsäuren in Proben
US6468740B1 (en) 1992-11-05 2002-10-22 Affymetrix, Inc. Cyclic and substituted immobilized molecular synthesis
US6287850B1 (en) * 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
US6121048A (en) * 1994-10-18 2000-09-19 Zaffaroni; Alejandro C. Method of conducting a plurality of reactions
US6720149B1 (en) * 1995-06-07 2004-04-13 Affymetrix, Inc. Methods for concurrently processing multiple biological chip assays
ES2180241T3 (es) * 1998-05-06 2003-02-01 Roche Diagnostics Gmbh Eliminacion de interferencias causadas por factores reumaticos.
US6545264B1 (en) 1998-10-30 2003-04-08 Affymetrix, Inc. Systems and methods for high performance scanning
ES2257095T3 (es) * 1998-12-01 2006-07-16 Viral Antigens, Inc. Especificidad mejorada en la deteccion de anticuerpos igm de anti-rubeola.
US6455007B1 (en) * 2000-06-13 2002-09-24 Symyx Technologies, Inc. Apparatus and method for testing compositions in contact with a porous medium
FR2864624A1 (fr) * 2003-12-24 2005-07-01 Inodiag Methode de diagnostic serologique des maladies infectieuses par immunodetection d'antigene microbien comprenant le controle de reaction faussement positive ou negative
US8445293B2 (en) * 2005-02-09 2013-05-21 Rapid Pathogen Screening, Inc. Method to increase specificity and/or accuracy of lateral flow immunoassays
CN106290912A (zh) * 2016-08-12 2017-01-04 泰州泽成生物技术有限公司 一种IgM抗体检测用吸附剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008473B1 (de) * 1978-08-24 1983-06-01 Akzo N.V. Verfahren zum Nachweis und/oder zur Bestimmung eines antigen-spezifischen Immunoglobulins, immunologische Reagenzien und Reagenzsatz zur Verwendung in diesem Bestimmungsverfahren
US4292403A (en) * 1978-08-24 1981-09-29 Akzona Incorporated Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins
US4434227A (en) * 1982-02-08 1984-02-28 Abbott Laboratories Immunoassay for class specific immunoglobulin antibodies
IL80129A0 (en) * 1986-09-23 1986-12-31 Savyon Diagnostics Ltd Method for the determination of igm and iga immunoglobulins and reagents therefor
JPH0754322B2 (ja) * 1988-11-07 1995-06-07 三洋化成工業株式会社 免疫学的定量法および検査用試薬
US5556745A (en) * 1994-06-03 1996-09-17 Sch+E,Uml U+Ee Pbach; J+E,Uml O+Ee Rg Method for the detection and quantitative determination of antigen in a test sample containing immune complexes of antigen bound to antibodies and to rheumatoid factors

Also Published As

Publication number Publication date
US5698393A (en) 1997-12-16
DE69626027T2 (de) 2003-11-20
CA2230644A1 (en) 1997-02-27
JPH11511255A (ja) 1999-09-28
EP0846268A1 (de) 1998-06-10
JP3675837B2 (ja) 2005-07-27
WO1997007401A1 (en) 1997-02-27
DE69626027D1 (de) 2003-03-06
EP0846268B1 (de) 2003-01-29
ES2192611T3 (es) 2003-10-16

Similar Documents

Publication Publication Date Title
ATE231973T1 (de) Verfahren zur elimination der interferenz des rheumatoiden faktors in diagnostischen tests
DE69632056D1 (de) Für natives prp-sc spezifische antikörper
DE69614205T2 (de) Verfahren und vorrichtung zur bestimmung eines analyten, insbesondere eines bakteriums, auf magnetischem wege
DE68928007T2 (de) Antigene Zusammensetzungen aus Fragmenten von Campylobacter pylori und Verfahren zu ihrer Herstellung und Verwendung
MX9701877A (es) Inmunoensayo para h. pylori en especimenes fecales.
DE68928427T2 (de) Antikörper mit modifiziertem Kohlenhydratgehalt und Verfahren zur Herstellung und Verwendung
DE69516007T2 (de) Verfahren zum nachweiss von antikörpern
DE3852996T2 (de) Immunoassayverfahren zum Nachweis von Antigenen.
ES2148577T3 (es) Eliminacion de interferencias causadas por factores reumatoides por medio de anticuerpos anti-fd.
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
DE59511101D1 (de) Metallchelat-markierte peptide
ATE225938T1 (de) Verfahren zur durchführung eines immunoassays in einem mehrphasensystem
Lin et al. Determination of the dissociation constant of phosvitin–anti-phosphoserine interaction by affinity capillary electrophoresis
EP0254081A3 (de) Verfahren zur Feststellung spezifisches Protein
ATE462975T1 (de) Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers
ATE185900T1 (de) Festphasen-filtrationsverfahren zur antigen- und antikörperprüfung in der blutgruppen-serologie, und testsatz
CA2434694A1 (en) Detection and quantification of cripto-1
DE50101435D1 (de) Verfahren zum nachweis von helicobacter pylori und heilmanii
DE59309999D1 (de) Verfahren zum Nachweisen von Antikörpern und Antigenen
DE59906849D1 (de) Verfahren zum spezifischen Nachweis von glykosilierten Proteinen
ATE347108T1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp
ATE171545T1 (de) Verfahren zur bestimmung des lysingehaltes von samen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0846268

Country of ref document: EP

REN Ceased due to non-payment of the annual fee